- Home
- ATNM vs UPLD Comparison
ATNM vs UPLD Comparison
Compare ATNM & UPLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- UPLD
- Stock Information
- Founded
- ATNM 2000
- UPLD 2010
- Country
- ATNM United States
- UPLD United States
- Employees
- ATNM N/A
- UPLD N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- UPLD Computer Software: Prepackaged Software
- Sector
- ATNM Health Care
- UPLD Technology
- Exchange
- ATNM Nasdaq
- UPLD Nasdaq
- Market Cap
- ATNM 49.0M
- UPLD 51.0M
- IPO Year
- ATNM N/A
- UPLD 2014
- Fundamental
- Price
- ATNM $1.63
- UPLD $2.05
- Analyst Decision
- ATNM Strong Buy
- UPLD Hold
- Analyst Count
- ATNM 3
- UPLD 1
- Target Price
- ATNM $4.67
- UPLD N/A
- AVG Volume (30 Days)
- ATNM 238.4K
- UPLD 210.9K
- Earning Date
- ATNM 08-12-2025
- UPLD 07-31-2025
- Dividend Yield
- ATNM N/A
- UPLD N/A
- EPS Growth
- ATNM N/A
- UPLD N/A
- EPS
- ATNM N/A
- UPLD N/A
- Revenue
- ATNM N/A
- UPLD $267,713,000.00
- Revenue This Year
- ATNM N/A
- UPLD N/A
- Revenue Next Year
- ATNM N/A
- UPLD N/A
- P/E Ratio
- ATNM N/A
- UPLD N/A
- Revenue Growth
- ATNM N/A
- UPLD N/A
- 52 Week Low
- ATNM $1.03
- UPLD $1.69
- 52 Week High
- ATNM $7.16
- UPLD $5.64
- Technical
- Relative Strength Index (RSI)
- ATNM 50.10
- UPLD 50.44
- Support Level
- ATNM $1.54
- UPLD $1.86
- Resistance Level
- ATNM $1.89
- UPLD $2.89
- Average True Range (ATR)
- ATNM 0.13
- UPLD 0.21
- MACD
- ATNM -0.01
- UPLD 0.03
- Stochastic Oscillator
- ATNM 36.59
- UPLD 18.45
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About UPLD Upland Software Inc.
Upland Software Inc is a software company. It provides cloud-based software applications in three categories: Knowledge Management that provides solutions designed to help organizations capture, organize, and distribute information to employees and customers. Content Lifecycle and Workflow Automation offers solutions that support document management, compliance, and process efficiency across various industries. Digital Marketing solutions that provides tools for audience engagement, campaign management, and content distribution across digital channels.